financetom
Business
financetom
/
Business
/
--Street Color: Walt Disney to Reportedly Invest $17 Billion in Florida Parks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Street Color: Walt Disney to Reportedly Invest $17 Billion in Florida Parks
Jun 5, 2024 10:31 AM

01:12 PM EDT, 06/05/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 101.57, Change: -1.77, Percent Change: -1.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Symbotic Acquires Robotics Company OhmniLabs
Symbotic Acquires Robotics Company OhmniLabs
Dec 12, 2024
04:54 PM EST, 12/12/2024 (MT Newswires) -- Symbotic ( SYM ) said late Thursday it has closed its acquisition of robotics company OhmniLabs. The company said OhmniLabs offers autonomous disinfection and telepresence robots. ...
EVgo Closes $1.25 Billion DOE Loan Facility to Fund Charging Network Expansion
EVgo Closes $1.25 Billion DOE Loan Facility to Fund Charging Network Expansion
Dec 12, 2024
04:53 PM EST, 12/12/2024 (MT Newswires) -- EVgo ( EVGO ) said Thursday that it closed a $1.25 billion guaranteed loan facility from the US Department of Energy's Loan Programs Office. The loan facility is under the department's Title 17 clean energy financing program that will support the company's efforts to build 7,500 new fast-charging stalls nationwide, according to EVgo...
Corcept Therapeutics Phase 4 Trial of Korlym Shows Hemoglobin A1c Reduction in Patients With Hypercortisolism, Diabetes
Corcept Therapeutics Phase 4 Trial of Korlym Shows Hemoglobin A1c Reduction in Patients With Hypercortisolism, Diabetes
Dec 12, 2024
04:54 PM EST, 12/12/2024 (MT Newswires) -- Corcept Therapeutics ( CORT ) said late Thursday that its phase 4 Catalyst trial of Korlym showed a reduction in hemoglobin A1c in patients with hypercortisolism, or Cushing's syndrome, and difficult-to-control type 2 diabetes, meeting the study's primary endpoint. Korlym-treated patients demonstrated a 1.47% reduction in hemoglobin A1c, compared with a 0.15% decrease...
Maersk sees global trade growth rising as much as 7% in 2025, exec says
Maersk sees global trade growth rising as much as 7% in 2025, exec says
Dec 12, 2024
(This Dec. 11 story has been corrected after the company clarified that van der Steene was referring to global trade growth forecast, not global container volumes, in the headline and in paragraph 1) By Siddharth Cavale NEW YORK (Reuters) - Maersk expects global trade growth rising as much as 7% next year, bolstered by strong demand from the United States...
Copyright 2023-2026 - www.financetom.com All Rights Reserved